Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility

Health Canada is offering an option for a rolling review of a new drug submission (NDS) or supplement to a new drug submission (SNDS) that meets specific eligibility conditions. Sponsors nearing the end of clinical development of a drug can apply to Health Canada for rolling review status for a forthcoming drug submission.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ébauche des lignes directrices sur la gestion des examens en continu des présentations de drogues : Processus d’examen en continu, admissibilité
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2023-01-11 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["présentations de médicaments", "gestion des examens continus", "présentations de médicaments", "processus d'examen continu", "admissibilité"], "en": ["drug submissions", "management-of-rolling reviews", "drug submissions", "rolling review process", "eligibility"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source